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INTRODUCTION
Dynamic susceptibility contrast (DSC) perfusion magnetic reso-
nance imaging (MRI) is a frequently used standard technique to
assess cerebral perfusion. It relies on the first passage of contrast
agent through the brain tissue (1) and allows estimation of multi-
ple perfusion parameters, such as relative cerebral blood volume
(rCBV), relative cerebral blood flow (rCBF), mean transit time
(MTT), and time to maximum (Tmax) of the residue function with
deconvolution. Of these DSC parameters, rCBV and rCBF are com-
monly used for brain tumor perfusion, including grading (2, 3),
diagnosing (3-5), monitoring treatment (6), differentiating tumor
recurrence from radiation necrosis (1, 7) etc.
Meanwhile, several studies have shown that the Tmax parame-
ter, which is the time to maximum of the residue function after
deconvolution, was reliable in evaluating cerebral hemodynamics
(8, 9). It represents the delay in contrast agent arrival between the
arterial input function (AIF) and the brain tissue (9, 10).
As an alternative to DSC MRI, arterial spin labeling (ASL) has
been considered as a comparable perfusion technique for evalu-
ating brain tumor angiogenesis (11-13). ASL is non- invasive and
uses magnetically labeled proton in the arterial blood water as an
endogenous tracer to quantify CBF (14). ASL perfusion imaging
has been continuously improving with three-dimensional (3D) im-
aging and background suppression, higher signal - to-noise ratio
(SNR), and low artifacts (15, 16). It would be a desirable perfusion
method without the use of exogenous contrast agent ; however,
the utility of ASL has been challenging in clinical practice due to
transit time effect (17, 18).
In stroke assessment in which the hypoperfused area is identi-
fied, good correlations have been shown between ASL and DSC
MRI parameters, including Tmax and MTT (8, 19). It has also
shown that DSC Tmax could assess the effect transit time on ASL
perfusion (19). The purpose of this study was to compare ASL CBF
with DSCMRI parameters including new parameter Tmax, and
to assess the influence of transit time in ASL for brain tumors.
MATERIALS AND METHODS
Patients
Patients with brain tumor (n=30 ; 11 women, 19 men ; mean
ageSD, 58.2614.02 years) prospectively underwent MRI ex-
aminations, including both ASL and DSC at the Tokushima Uni-
versity Hospital between December 2009 and February 2012. The
inclusion criteria were as follows ; (1) the patient was histopa-
thologically confirmed, (2) the patient was examined both 3D ASL
and DSC MRI at the same machine, (3) the patient has undergone
MRI examinations prior to the treatment.
The patients who were diagnosed with high-grade gliomas (HGG)
(n=21), primary central nervous system lymphomas (PCNSL)
(n=4), brain metastasis (n=4), and hemangioblastoma (n=1) were
included in this study.
Gliomas were graded according to the 2007 World Health Or-
ganization (WHO) classification. A total of 14 patients had glioblas-
toma (GBM) (WHO IV), 4 had anaplastic astrocytoma (WHO III),
2 had anaplastic oligoastrocytoma (WHO III), and 1 had anaplastic
oligodendroglioma (WHO III). Among four patients with brain
metastasis, the primary sites were the lungs, bladder, ovaries, and
colon.
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In our study, we excluded non enhancing tumors or low-grade
gliomas for the following reasons ; (1) The regions of the interest
(ROI)’s were only placed on the contrast enhancement lesions of
the tumors, (2) There were a few number of low-grade gliomas
which met the inclusion criteria during the study period.
This study was approved by the local institutional ethics commit-
tee and written informed consent was obtained from all patients.
MRI
MRI was performed on a 3-T scanner (Discovery 750, GE Health-
care, WI) using a standard 8-channel head coil. All MRI examina-
tions were performed with DSC MRI, ASL, and conventional se-
quences, including post contrast enhanced T1 -weighted images
(CE-T1WI), T2WI, FLAIR, T1WI, and DWI.
ASL was performed by pseudo-continuous labeling, background
suppression, and a stack of spiral 3D fast -spin echo imaging se-
quences. ASL was acquired based on the following parameters :
512 sampling points on eight spirals, field of view (FOV) 24 cm,
repetition time (TR) 4632 ms, echo time (TE) 10.5 ms, receiver
band with 62.50 kHz, reconstructed matrix size 6464, number
of excitation (NEX) 2, labeling duration 1525 ms, post- labeling
delay 1525 ms, slice thickness 4 mm, number of slices 36, and ac-
quisition time of 3 : 15 min. Inplane resolution was 3.63.6 mm.
The rCBV, rCBF, Tmax, and MTT were obtained by DSC MRI,
which was performed using gradient-echo echo-planar imaging
(GE-EPI), FOV 24 cm, TR 1990 ms, TE 30 ms, reconstructed ma-
trix size 128128, flip angle 90 degrees, ASSET factor 2, NEX 1,
slice thickness 4 mm, number of slices 20, and acquisition time
100 s (50 phases).
A standard single dose of 0.1 mmol/kg body weight of a Gd-
based contrast agent (Magnevist, Bayer HealthCare, Berlin, Ger-
many) with saline (20 ml) was injected intravenously at a rate of
2.5 ml/s by using a power injector.
Data analysis
The DSC MRI and ASL images were transferred to a workstation
with commercially available software (Advantage workstation AW
4.6, GE Healthcare Milwaukee, WI). The rCBF, rCBV, Tmax, and
MTT that were derived from DSC MRI were processed using Brain-
stat AIF post-processing software (GE Healthcare, Milwaukee, WI).
AIF pixels were generated by using automatic vessel detection and
motion correction was enabled prior to post-processing. The resi-
due function was determined by using deconvolution with singular
value decomposition (SVD) with a block circulant matrix (20).
The ROI placement of the present study is shown in Fig. 1. ROIs
were defined by two neuroradiologists, based on maximal signal
enhancement of the tumor lesions on CE-T1WI and by avoiding
necrotic and non-tumoral areas. If a tumor had rim enhancement
on CE-T1WI, ROIs were placed only on the contrast -enhancing
rim for measurement of the parameters. All ROIs were copied to
maps of ASL CBF, DSC rCBV, rCBF, Tmax, and MTT parameters.
In addition, another circular ROI, measuring approximately 1 cm
in diameter, was placed on the unaffected contralateral white mat-
ter (WM) to obtain normalized ratios of the perfusion parameters.
The ratio of all parameters was estimated by dividing the mean
perfusion value of the tumor by the mean perfusion value of WM
(mean perfusion valuetumor/mean perfusion valuewm).
Statistical analysis
All statistical analyses were performed using SPSS Ver. 20 (IBM,
Armonk, NY, USA). Pearson’s correlation and Linear regression
were used to assess the relationships of ASL with each of the DSC
MRI parameters. Pearson’s correlation test was two-tailed and a p
value of less than 0.05 was considered to be significant. Data were
presented as meanstandard deviations (SD).
RESULTS
Fig. 2 shows the relationships of ASL with all DSCMRI parame-
ters in brain tumors. ASL CBF ratio had the highest significant
correlation with DSC rCBF ratio (r=0.78, p0.001). There was a
strong correlation between ASL CBF ratio and DSC rCBV ratio
in brain tumors (r=0.74, p0.001). Interestingly, ASL CBF ratio
was negatively correlated with DSC Tmax ratio (r=-0.43, p0.05),
but it was not correlated with DSC MTT ratio (r=-0.30, p=0.126).
The correlations between ASL CBF and the DSC MRI parameters
in brain tumors are shown in the Table 1. There were strong cor-
relations between DSC rCBF ratio and rCBV ratio (r=0.86, p
0.001) and between Tmax ratio and MTT ratio (r=0.76, p0.001).
Tmax ratio did not show significant correlation with rCBF ratio or
rCBV ratio in the present study.
The mean ratios of all tumors were 2.711.63 for ASL CBF,
2.271.06 for DSC rCBF, 2.911.46 for rCBV, 1.310.74 for
Tmax, and 1.540.96 for MTT. The mean values of the parameters
for the tumor groups are shown in Table 2. Compared with PCNSL
and metastatic brain tumors, HGG showed higher values of ASL
CBF, DSC rCBF, and rCBV. The ratio of the metastasis was higher
than that of PCNSL for ASL CBF,DSC rCBF and rCBV. Tmax dem-
onstrated a higher value for HGG than for PCNSL and metastasis.
The only one hemangioblastoma demonstrated the highest per-
fusion values in ASL CBF, DSC rCBF, and rCBV (Table 2). For
Tmax, hemangioblastoma demonstrated the lowest value com-
pared with other tumors. Among the perfusion parameters, MTT
was similar in all tumor types.
DISCUSSION
In the past, there have been several brain tumor studies that
compared ASL CBF with DSC rCBF (11, 21, 22) or with both DSC
rCBF and rCBV parameters (12, 13, 23, 24). The present study in-
cluded comparisons of ASL CBF with additional DSC MRI parame-
ters, including Tmax and MTT.
Fig. 1. Contrast enhanced T1 -weighted image (CE-T1WI) of a glioblas-
toma. (1) Tumor region of interest (ROI)s were placed on the CE-T1WI
and then copied to all corresponding perfusion maps. (2) Normal contra-
lateral white matter (WM) was used as reference to obtain ratios of the
perfusion parameters.
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Based on our results, ASL CBF could be an equally efficient
parameter to DSC MRI for the evaluation of brain tumor perfusion.
Particularly, DSC rCBF had the highest correlation with ASL CBF
in brain tumors, probably because both depend on blood flow rate.
The higher ASL CBF ratio compared with the DSC rCBF ratio in
the study could be explained by ASL underestimation of WM with
a long transit time (11, 25).
In addition, the present study showed a moderate negative cor-
relation between ASL CBF and DSC Tmax in brain tumors (Fig. 2C).
This finding suggests that ASL CBF and DSC Tmax could be in-
fluenced by some similar factors. ASL perfusion is sensitive to the
effects of transit time, leading to inaccurate ASL CBF estimation
A B
C D
Fig. 2. The graphs show the correlations between ASL CBF and each of the DSC MRI parameters in brain tumors (n=30). (A) ASL CBF ratio
and DSC rCBF ratio, (B) ASL CBF ratio and DSC rCBV ratio, (C) ASL CBF ratio and DSC Tmax ratio, and (D) ASL CBF ratio and DSCMTT ratio.
ASL, arterial spin labeling ; CBF, cerebral blood flow ; DSC, dynamic susceptibility contrast ; rCBF, relative cerebral blood flow ; rCBV, relative
cerebral blood volume ; Tmax, time to maximum ; MTT, mean transit time.
Table 1. Correlation analysis between ASL and DSC MRI parameters for brain tumors (n=30)
ASL CBF
ratio
DSC rCBF
ratio
DSC rCBV
ratio
DSC Tmax
ratio
DSC MTT
ratio
ASL CBF ratio ?
DSC rCBF ratio 0.78** ?
DSC rCBV ratio 0.74** 0.86** ?
DSC Tmax ratio -0.43* -0.10 -0.07 ?
DSC MTT ratio -0.30 0.01 0.12 0.76** ?
Pearson’s correlation (two- tailed). *Correlation significant, p0.05 ; **correlation significant, p0.01. ASL, arterial spin labeling ; CBF, cerebral
blood flow ; DSC, dynamic susceptibility contrast ; MRI, magnetic resonance imaging ; rCBF, relative cerebral blood flow ; rCBV, relative cerebral
blood volume ; Tmax, time to maximum ; MTT, mean transit time.
The Journal of Medical Investigation Vol. 63 August 2016 177
(15, 16). Similarly, Tmax parameter derived from DSC could be
strongly affected by tracer arrival delay, unlike in deconvolution
methods (9, 10). Therefore, DSC Tmax has been considered a
normalized bolus arrival time by deconvolution (26).
As known that DSC rCBF, rCBV and MTT are related parame-
ters to creating each other as the theory of central volume (MTT=
CBV/CBF ratio) (20). DSC rCBF, rCBV and MTT mostly depend
on tracer dispersion, while Tmax particularly remains on tracer ar-
rival delay (27, 28). Besides, we used a delay- insensitive decon-
volution analysis (20) to compensate the tracer arrival differences.
This method is applied to perform the delay- insensitive estimation
of DSC CBF and MTT. From these findings, ASL CBF and DSC
Tmax are both sensitive to tracer arrival differences, unlike other
DSC perfusion parameters.
In the present analysis, we did not find a significant correlation
between ASL CBF and DSC MTT (Fig. 2D). According to the pre-
vious works, DSC MTT is different from transit time in ASL imag-
ing. ASL transit time is defined as the duration time for the labeled
blood between labeling region and brain tissue, whereas DSC
MTT represents the mean time for contrast agent to traverse
from the arterial to the venous end (19, 29). It noted that transit
time in ASL is conceptually similar with DSC Tmax. To the best of
our knowledge, this report is the first study to demonstrate rela-
tionship between ASL CBF and DSC Tmax in brain tumors, indi-
cating the sensitivity of transit time on ASL in brain tumors.
The vascularity of malignant tumors are usually expanded, tor-
tuous and leaky, containing the variable blood transit times (30).
The labeled blood reaches the tumor regions within different times
due to heterogeneous blood supply. ASL CBF couldbe underesti-
mated by transit delay of labeled blood in the core of the tumors,
where arterial supply is delayed compared with the outer regions
(30, 31). Alternatively, the peripheral or hypervascularized regions
of the tumor probably present short arrival time for the labeled
blood (5).
Moreover, the relationship of ASL CBF with DSC Tmax in brain
tumors may be accounted for by tumor vascularization. It has been
said that ASL was very sensitive in detecting hypervascularity by
reflecting microvascular density (12, 32, 33). The highly vascular
malignant tumors, such as HGG, metastasis, hemangioblastoma,
and PCNSL that were included in this study demonstrated high
perfusion values. In the present study, the hyperperfused tumors
often showed higher perfusion values and lower Tmax values (Fig.
3-6). Further, the most hypervascular tumor, hemangioblastoma,
demonstrated the highest ASL CBF value and the lowest DSC Tmax
Table 2. Comparison of perfusion imaging parameters among the different types of brain tumors
Ratio All tumors
(n=30)
HGG
(n=21)
PCNSL
(n=4)
Metastasis
(n=4)
Hemangioblastoma
(n=1)
ASL CBF 2.71 (1.63) 2.79 (1.46) 1.73 (1.02) 2.10 (0.59) 7.62
DSC rCBF 2.27 (1.06) 2.31 (0.94) 1.51 (0.54) 2.02 (0.96) 5.27
DSC rCBV 2.91 (1.46) 2.96 (1.22) 1.53 (0.59) 2.87 (1.58) 6.14
DSC Tmax 1.31 (0.74) 1.44 (0.84) 1.15 (0.42) 1.04 (0.22) 0.50
DSC MTT 1.54 (0.96) 1.54 (1.03) 1.62 (0.93) 1.53 (0.91) 1.54
The values shown are mean (standard deviation). ASL, arterial spin labeling ; CBF, cerebral blood flow ; DSC, dynamic susceptibility contrast ; rCBF,
relative cerebral blood flow ; rCBV, relative cerebral blood volume ; Tmax, time to maximum ; MTT, mean transit time ; HGG, high grade glioma ;
PCNSL, primary central nervous lymphoma.
Fig. 3. MRI images of a patient with glioblastoma in the right temporal lobe with peritumoral edema. The tumor shows contrast rim-enhancement
on (A) CE-T1WI and hyperperfusion on the (B) ASL CBFmap, (C) DSC rCBF map, and (D) DSC rCBV map. (E) Tmax map demonstrates a corre-
sponding perfusion defect in the tumor lesion that disappears on the (F) DSC MTT map. MRI, magnetic resonance imaging ; CE-T1WI, contrast
enhanced T1 weighted image ; ASL, arterial spin labeling ; CBF, cerebral blood flow ; DSC, dynamic susceptibility contrast ; rCBF, relative cerebral
blood flow ; rCBV, relative cerebral blood volume ; Tmax, time to maximum ; MTT, mean transit time.
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value compared with those of other tumor groups (Table 2).
In this study, we did not focus on comparing perfusion parame-
ters by tumor histology because of the small number of tumor
types. Nevertheless, the results of highest perfusion values in HGG
and lowest perfusion values in PCNSL are concordant with previ-
ous studies (3-5, 33). The DSC Tmax value decreased in trend from
HGG to PCNSL to metastasis. However, some grade III glioma,
such as anaplastic oligodendroglioma, anaplastic oligoastrocy-
toma showed very high Tmax values compared with other HGG.
Furthermore, the number of PCNSL was very small and relatively
consistent in Tmax. The DSC MTT perfusion parameter was con-
stant in all tumor groups.
Fig. 4. MRI images of a patient with primary CNS lymphoma.The tumor demonstrate contrast -enhancement on (A) CE-T1WI and hyperperfusion
on the (B) ASL CBFmap, (C)DSC rCBFmap, and (D)DSC rCBVmap. The tumor shows a slightly decreased perfusion signal on the (E) DSC Tmax
map and but not on the (F) DSC MTT map. MRI, magnetic resonance imaging ; CE-T1WI, contrast enhanced T1 weighted image ; ASL, arterial
spin labeling ; CBF, cerebral blood flow ; DSC, dynamic susceptibility contrast ; rCBF, relative cerebral blood flow ; rCBV, relative cerebral blood
volume ; Tmax, time to maximum ; MTT, mean transit time.
Fig. 5. MRI images of a patient with brain metastasis. The tumor shows contrast -enhancement on (A) CE-T1WI and hyperperfusion on the (B)
ASL CBFmap, (C)DSC rCBFmap, and (D)DSC rCBVmap. The tumor lesion shows a decreased perfusion signal on the (E) DSC Tmax map and,
an increased perfusion signal on the (F)MTT map. MRI, magnetic resonance imaging ; CE-T1WI, contrast enhanced T1 weighted image ; ASL,
arterial spin labeling ; CBF, cerebral blood flow ; DSC, dynamic susceptibility contrast ; rCBF, relative cerebral blood flow ; rCBV, relative cerebral
blood volume ; Tmax, time to maximum ; MTT, mean transit time.
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ASL may be an alternative method to DSC MRI for cerebral per-
fusion. ASL is completely non-contrast and is repeatable, making
it a suitable option to evaluate brain tumor progression and treat-
ment response, especially for patients with renal insufficiency. The
disadvantages of ASL, compared with DSC MRI, are transit time
sensitivity, lower SNR and longer acquisition time. However, ASL
perfusion imaging was recently improved with higher SNR, lower
artifacts, and 3D imaging with background suppression (15, 16).
It would be interesting to study DSC Tmax in brain tumors. DSC
Tmax is a novel and complex parameter discussed in the literature
(9, 10). As from our data, shorter value of DSC Tmax is often re-
lated with hyperperfused tumors on ASL imaging. DSC Tmax is
practically available for free and heterogeneously different from
other DSC MRI parameters ; therefore, it may contain microvas-
cular information on brain tumors.
There were some limitations in the present study, such as the
few tumor types that were included. The only one hemangioblas-
toma included in the current study that is insufficient to represent
the tumor group. In the future, larger studies would be needed to
validate the results of our study, especially the correlation of ASL
CBF with DSC Tmax and the significance of DSC Tmax in brain
tumors. Because DSC Tmax is a complex parameter, it could be
affected by many factors (9). The physiologic and experimental
mechanisms of the parameter should be defined well in future stud-
ies. In this work, we did not use a pre-dose of contrast agent or
leakage correction to compensate T1 leakage effect of Gd when
obtains DSC MRI parameters, which is possible to affect the esti-
mation accuracy (1).
CONCLUSIONS
The strong correlations were between ASL CBF and DSC rCBF,
ASL CBF and DSC rCBV in brain tumors, which are consistent with
previous studies. In addition, a negative correlation was found be-
tween ASL CBF and DSC Tmax in brain tumors, suggesting that
ASL CBF and DSC Tmax parameters would be affected by transit
time, which is one of the reasons why ASL CBF is different from
DSC rCBF and DSC rCBV. The decreased DSC Tmax value may
suggest high vascularity in a tumor.
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